Onconic Therapeutics Inc. (KOSDAQ:476060)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
Biotechnology	95.00M	60.00M
Total	95.00M	60.00M

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021
Period Ending	Dec 31, 2022	Dec 31, 2021
South Korea	95.00M	60.00M
Total	95.00M	60.00M

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 12, 2026

Data Sources Report a data error